← Back to Screener
Cronos Group Inc. Common Share (CRON)
Price$2.76
Favorite Metrics
Price vs S&P 500 (26W)-3.63%
Price vs S&P 500 (4W)2.29%
Market Capitalization$1.40B
P/E Ratio (Annual)24.31x
All Metrics
P/CF (Annual)39.59x
Book Value / Share (Quarterly)$2.87
P/TBV (Annual)0.93x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)16.84%
Cash Flow / Share (Quarterly)$-0.00
Price vs S&P 500 (YTD)-0.59%
Gross Margin (TTM)42.81%
Net Profit Margin (TTM)-6.44%
EPS (TTM)$-0.02
10-Day Avg Trading Volume0.12M
EPS Excl Extra (TTM)$-0.02
Revenue Growth (5Y)25.70%
EPS (Annual)$-0.02
ROI (Annual)-0.86%
Gross Margin (Annual)42.81%
Net Profit Margin (5Y Avg)-154.41%
Cash / Share (Quarterly)$2.18
P/E Basic Excl Extra (TTM)27.67x
Revenue Growth QoQ (YoY)46.96%
EPS Growth (5Y)-49.98%
P/E Normalized (Annual)24.31x
ROA (Last FY)-0.79%
Revenue Growth TTM (YoY)24.63%
EBITD / Share (TTM)$-0.07
ROE (5Y Avg)-9.62%
Operating Margin (TTM)-11.87%
Cash Flow / Share (Annual)$-0.00
P/B Ratio0.94x
P/B Ratio (Quarterly)0.92x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.58x
Net Interest Coverage (TTM)-44.46x
ROA (TTM)-0.80%
EPS Growth QoQ (YoY)212.04%
EV / EBITDA (TTM)5805.49x
EPS Incl Extra (Annual)$-0.02
Current Ratio (Annual)19.59x
Quick Ratio (Quarterly)18.45x
3-Month Avg Trading Volume0.22M
52-Week Price Return51.02%
EV / Free Cash Flow (Annual)37.72x
P/E Incl Extra (TTM)27.67x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.84
P/S Ratio (Annual)6.99x
Asset Turnover (Annual)0.12x
52-Week High$4.66
Operating Margin (5Y Avg)-232.78%
EPS Excl Extra (Annual)$-0.02
CapEx CAGR (5Y)-5.94%
Tangible BV CAGR (5Y)-7.95%
26-Week Price Return5.11%
Quick Ratio (Annual)18.45x
13-Week Price Return3.06%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)19.59x
Enterprise Value$232.22
Revenue / Share Growth (5Y)23.53%
Asset Turnover (TTM)0.12x
Book Value / Share Growth (5Y)-9.61%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.10x
Pretax Margin (Annual)-11.68%
Cash / Share (Annual)$2.18
3-Month Return Std Dev34.40%
Gross Margin (5Y Avg)14.22%
Net Income / Employee (TTM)$-0
ROE (Last FY)-0.86%
Net Interest Coverage (Annual)-0.43x
EPS Basic Excl Extra (Annual)$-0.02
P/FCF (TTM)56.01x
Receivables Turnover (TTM)5.92x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.02
Receivables Turnover (Annual)5.92x
ROI (TTM)-0.87%
P/S Ratio (TTM)6.99x
Pretax Margin (5Y Avg)-146.04%
Revenue / Share (Annual)$0.38
Tangible BV / Share (Annual)$2.84
Forward P/E36.80x
Price vs S&P 500 (52W)15.93%
P/E Ratio (TTM)27.67x
Year-to-Date Return2.78%
5-Day Price Return3.64%
EPS Normalized (Annual)$-0.02
ROA (5Y Avg)-9.20%
Net Profit Margin (Annual)-6.44%
Month-to-Date Return5.11%
Cash Flow / Share (TTM)$-0.34
EBITD / Share (Annual)$-0.07
Operating Margin (Annual)-11.87%
LT Debt / Equity (Annual)0.06x
P/CF (TTM)39.59x
ROI (5Y Avg)-9.62%
P/E Excl Extra (TTM)27.67x
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.02
P/TBV (Quarterly)0.93x
P/B Ratio (Annual)0.92x
Inventory Turnover (TTM)2.10x
Pretax Margin (TTM)-11.68%
Book Value / Share (Annual)$2.87
Price vs S&P 500 (13W)0.20%
Net Margin Growth (5Y)-62.81%
Beta1.40x
P/FCF (Annual)180.00x
Revenue / Share (TTM)$0.38
ROE (TTM)-0.87%
52-Week Low$2.35
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.14
4.13
4.11
4.11
Industry Peers — Pharmaceutical Preparations(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
CRONCronos Group Inc. Common Share | 6.99x | 24.63% | 42.81% | -49.98% | $2.76 |
TLRYTilray Brands, Inc. Common Stock | 0.97x | 3.82% | 27.68% | — | $7.15 |
CGCCanopy Growth Corporation Common Shares | 2.55x | 0.59% | 26.56% | — | $1.20 |
NAGENiagen Bioscience, Inc. Common Stock | 3.01x | 29.95% | 64.28% | — | $4.87 |
USNAUSANA Health Sciences Inc | 0.41x | 5.88% | 78.29% | -37.04% | $20.64 |
SNDLSundial Growers Inc. Common Shares | 0.58x | 2.82% | 27.33% | — | $1.54 |
MDWDMediWound Ltd. | 13.35x | -16.14% | 19.19% | — | $17.35 |
ACBAurora Cannabis Inc. Common Shares | 0.77x | 16.54% | 1.35% | — | $3.72 |
BTMDBiote Corp. Class A Common Stock | 0.46x | -2.52% | 71.46% | -26.84% | $2.24 |
FTLFFitLife Brands, Inc. Common Stock | 1.29x | 1.34% | 37.58% | -20.04% | $8.99 |
NAIINatural Alternatives International Inc. | 0.13x | 10.92% | 9.06% | — | $2.76 |
About
Cronos Group Inc is a cannabis company with operations in Canada, Israel, and other markets, generating the majority of its revenue from Canada. The company's brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. Cronos focuses on cannabis research, technology, and product development to drive competitive differentiation.